Marc Ferrer
10Patents
1h-index
38Co-inventors
46Inventor score
Filing activity: Jul 29, 2014 → Feb 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9550742B2 | 11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists | Chemistry; Metallurgy | 20 | Active |
| US11253511B2 | Use of low dose emetine for inhibition of human cytomegalovirus (HCMV) | Emerging Cross-Sectional Technologies | 1 | Active |
| US11649218B2 | C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same | Chemistry; Metallurgy | 0 | Active |
| US11766423B2 | 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases | Human Necessities | 0 | Active |
| US11241436B2 | Autophagy inducers for treatment of CNS conditions | Human Necessities | 0 | Active |
| US11471460B2 | Autophagy modulators for use in treating cancer | Chemistry; Metallurgy | 0 | Active |
| US12208093B2 | Use of low dose emetine for inhibition of human cytomegalovirus (HCMV) | Emerging Cross-Sectional Technologies | 0 | Active |
| US12145922B2 | Selective D3 dopamine receptor agonists and methods of their use | Chemistry; Metallurgy | 0 | Active |
| US10202367B2 | Heterocyclic compounds and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11634404B2 | Selective D3 dopamine receptor agonists and methods of their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.